• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES, PR FOGARTY ARTERIAL EMBOLECTOMY CATHETER; FOGARTY EMBOLECTOMY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES, PR FOGARTY ARTERIAL EMBOLECTOMY CATHETER; FOGARTY EMBOLECTOMY CATHETER Back to Search Results
Model Number 120404FP
Medical Device Problem Code Material Fragmentation (1261)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Our product evaluation lab received one model number 120804fp catheter without any attached components.The balloon was deteriorated, and many holes were observed at the distal area.After cutting the proximal windings, the edges of holes did not appear to match up.Latex deterioration is a condition usually caused by age, excessive exposure to light, atmosphere, or ozone.It appears on the balloon surface as a maze of fine cracks or crazing.The condition may occur in a small area or cover the entire balloon.No visible damage was observed from both windings and catheter body.A device history record review was completed and documented that the device met all specifications upon distribution.An engineering evaluation has been initiated to assess for any manufacturing-related processes which could be correlated to the complaint.Complaint histories for all reported events are reviewed against trending control limits, and any excursions above the control limits are assessed and documented as part of this monthly review.
 
Event or Problem Description
It was reported that the balloon of the fogarty catheter model number 120404fp from lot 64052436, did not inflate during the inflation test before use in the patient.Blood was found on the device, but no infection.There were no patient complications reported.
 
Additional Manufacturer Narrative
Engineering evaluation was completed.A capa was initiated for the latex deterioration issue and a product risk assessment was needed.Complaint histories for all reported events are reviewed against trending control limits, and any excursions above the control limits are assessed and documented as part of this monthly review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FOGARTY ARTERIAL EMBOLECTOMY CATHETER
Common Device Name
FOGARTY EMBOLECTOMY CATHETER
Manufacturer (Section D)
EDWARDS LIFESCIENCES, PR
state rd indus pk 402 km 1.4
anasco PR 00610
Manufacturer (Section G)
EDWARDS LIFESCIENCES, PR
state rd indus pk 402 km 1.4
anasco PR 00610
Manufacturer Contact
jonathan diaz
1 edwards way
irvine, CA 92614
9492507258
MDR Report Key15917045
Report Number2015691-2022-09678
Device Sequence Number6544854
Product Code DXE
UDI-Device Identifier00690103205107
UDI-Public(01)00690103205107(17)240129(11)211030(10)64052436
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
PREAMENDMENT
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 01/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/29/2024
Device Model Number120404FP
Device Catalogue Number120404FP
Device Lot Number64052436
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/09/2022
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/15/2022
Supplement Date Received by Manufacturer12/20/2022
Initial Report FDA Received Date12/05/2022
Supplement Report FDA Received Date01/05/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/30/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-